Replies to post #104186 on Amarantus Bioscience Holdings Inc (AMBS)

[Riskreturn168]

If we were to be bought out today and we used an outstanding share figure of 800 million, our pps would be approximately $12 and a few cents! I don't think we'll hit a 10 billion market cap or get an offer for a 10 billion dollar buy out for a few years. It is possible in maybe 5 or 6 or 7 years. By that time LymPro's revenue will be approaching 1 billion per year. Lets assume our partner takes 20% of that leaving us with 800 million. If you multiply that times 8 to determine an appropriate market cap....that would put us at 6.4 billion. That could happen in 5 years. But by then we'll have MANF indications commercialized: Retinitis and Wolframs (Diabetes) Who knows what those indications could do to our market cap? So it is very possible that in 5 years we could have a combined market cap of 10 billion.

[joboggi]

The current market cap is $75 million. Take $10 billion and divide it by $75 Million and then multiply that number times the pps.

Oh, it seems unrealistic, that is because it is totally unrealistic.

Now, I really do think they will sell at some point, for $$$ based on MANF. I have no idea when that will happen.

Any transaction based on Lympro will not take place for at least two years, because there is no market for that outside of POSSIBLE research, if the test is accepted. IOW, it has to beat AMVID.

If it does beat AMVID, I will not be surprised, but it will mean that the data got better, which does not happen too often.

Personally, I am getting ready to sell on the day of the Copenhagen conference. Historically, that is an excellent time to sell AMBS for obvious reasons.

The fact that GC feels he needs to have a twitter conference in order to get the penny investors ready for the upcoming data tells me a LOT.

[Rotten Johnny]

$10.36 pps = $10-Bil. buyout

the stuff that dreams are made of.......